The purpose of this study is to determine if Amitiza (lubiprostone), a drug proven to be safe
and effective for chronic constipation, will also improve constipation symptoms in
Parkinson's Disease patients. We will also evaluate the impact of the drug on changes in
bowel movement consistency, quality of life and motor symptoms.